- $317.77bn
- $361.24bn
- $65.01bn
Brief: Protillion Biosciences Announces Drug Discovery Collaboration With Merck
Moderna announces executive changes ahead of potential launches
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)
Factbox: Global drugmakers invest billions to boost US presence
Brief: FDA Approves Belzutifan With Pembrolizumab For Adjuvant Treatment Of Renal Cell Carcinoma
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Race to launch weight-loss pill heats up as Novo wins UK approval
Brief: Merck Animal Health To Buy Targan For Undisclosed Price
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal (updated)
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal
Focus: Cancer vaccines based on mRNA advance, despite US cuts (updated)
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Cancer vaccines based on mRNA advance, despite US cuts
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: Merck And Gilead Provide Update On Phase 3 Keynote-D46/Evoke-03 Study
Live Markets: Wall Street's records line-up changes, Dow rallies as Nasdaq lags
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Focus: GLP-1 drugs may have a beneficial effect across many types of cancer